Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition. Urbanek-Quaing M, Chou YH, Gupta MK, Steppich K, et al. Hepatology 2025;82:739-754.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Urbanek-Quaing M, Chou YH, Gupta MK, Steppich K, et al. Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition. Hepatology 2025;82:739-754.
PMID: 39700467